Mitra Raj, Cheung Lance, Perry Patrick
School of Medicine, Department of Orthopedic Surgery, Stanford University, Stanford, CA 94305, USA.
Pain Physician. 2007 Nov;10(6):775-8.
Coccydynia is a rare but painful disorder characterized by axial coccygeal pain which is typically exacerbated by pressure. Management includes physical therapy/rectal manipulation, use of anti-inflammatory medications, modality use, coccygectomy, and fluoroscopically guided steroid injections. There are no studies documenting the efficacy of fluoroscopically guided coccygeal steroid injections in patients with coccydynia.
Retrospective chart review was used to collect data on 14 consecutive patients diagnosed with coccydynia who underwent a fluoroscopically guided coccygeal injection of 80 mg triamcinolone acetate and 2mg of 1% lidocaine over a 3-year period at a tertiary care academic medical center.
Using stepwise logistic regression, acute pain was determined to be the best predictor of relief. Fisher's exact test showed that those patients with pain lasting less then 6 months were significantly more likely to have greater than 50% relief (P=0.055). Patients with chronic pain longer than 6 months were not found to have pain relief of >50% to any statistical significance, but every patient with acute pain showed improvement.
Patients with acute pain (less then 6 months) are more likely to respond to fluoroscopically guided coccygeal steroid injections.
尾骨痛是一种罕见但疼痛的疾病,其特征为尾骨轴向疼痛,通常因受压而加重。治疗方法包括物理治疗/直肠推拿、使用抗炎药物、采用物理治疗方式、尾骨切除术以及在荧光镜引导下进行类固醇注射。尚无研究记录荧光镜引导下尾骨类固醇注射对尾骨痛患者的疗效。
采用回顾性病历审查,收集在一家三级医疗学术中心3年期间连续14例被诊断为尾骨痛且接受荧光镜引导下尾骨注射80毫克醋酸曲安奈德和2毫克1%利多卡因的患者的数据。
通过逐步逻辑回归分析,确定急性疼痛是缓解情况的最佳预测指标。Fisher精确检验显示,疼痛持续时间少于6个月的患者疼痛缓解超过50%的可能性显著更高(P = 0.055)。未发现慢性疼痛超过6个月的患者疼痛缓解超过50%具有任何统计学意义,但每例急性疼痛患者均有改善。
急性疼痛(少于6个月)的患者更有可能对荧光镜引导下尾骨类固醇注射产生反应。